Most autoantibody levels of aPF IgG, aβ2GP total Ig, and aCL IgM and IgG remained below a 2-fold increase over baseline (T1) after the first (T2) and second dose (T3) for all COVID-19 vaccines (Figure 2). The gene discussed is CD40LG; the disease is COVID-19.